Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002309 · ClinicalTrials.gov registry record · NA
A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients
A NA study of HIV Infections and Mycobacterium Avium-Intracellulare Infection, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 3
- Study locations
NCT00002309 is a NA study of HIV Infections and Mycobacterium Avium-Intracellulare Infection that has completed, run by Pfizer. The trial reports 3 study locations across 3 states.
The verdict
NCT00002309, a NA study of HIV Infections and Mycobacterium Avium-Intracellulare Infection, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 3
- Study locations
Study Summary
To evaluate the efficacy and safety of azithromycin administered once a week in the prevention of disseminated Mycobacterium avium complex (MAC) in severely immunocompromised HIV-infected patients with a CD4 count \< 100 cells/mm3.
Conditions Studied
Interventions
- DRUG Azithromycin
Study Locations (3)
California
- San Diego Naval Hosp - San Diego
North Carolina
- Womack Army Med Ctr / Med Clinic - Fort Bragg
Texas
- United States Air Force Med Ctr - Lackland Air Force Base
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002309
The ClinicalTrials.gov registry entry for NCT00002309 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.
NCT00002309 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, North Carolina, Texas.
Frequently Asked Questions
What is clinical trial NCT00002309 about?
NCT00002309 is a clinical study titled "A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients". To evaluate the efficacy and safety of azithromycin administered once a week in the prevention of disseminated Mycobacterium avium complex (MAC) in severely immunocompromised HIV-infected patients with a CD4 count \< 100 cells/mm3.
What is the current status of trial NCT00002309?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002309 study?
This clinical trial studies the following conditions: HIV Infections, Mycobacterium Avium-Intracellulare Infection.
What interventions are being tested in trial NCT00002309?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT00002309?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002309 being conducted?
This trial has 3 study locations across California, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
HIV Infections
All registered trials for this condition
Mycobacterium Avium-Intracellulare Infection
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.